News
Hematocrit is the percentage of red blood cells in a person‘s blood. A typical hematocrit range in adults is 36–54%. However, age, sex, and health conditions can influence hematocrit levels.
High hematocrit can be a sign of polycythemia, which is when you have too many red blood cells. This can cause your blood to become thicker and travel slower through your blood vessels and organs.
Induction therapy with twice-weekly rusfertide helped patients with polycythemia vera achieve target hematocrit below 45% without phlebotomy, according to a study presented at ASH Annual Meeting ...
A hematocrit test measures the proportion of RBCs in the blood, which is necessary to prevent conditions like anaemia. Written by: Tenzin Chodon Updated at: Jun 27, 2024 17:01 IST ...
SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed.
THE measurement of the packed red-cell volume (or hematocrit) of the venous blood has long been recognized as a useful aid in the study of blood in a large number of clinical conditions. The ...
Rates of all cardiovascular events, including those not counted in the primary endpoint, were 4.4% with low hematocrit versus 10.9% with high hematocrit (HR 2.69, 95% CI 1.19 to 6.12, P =0.02).
ATLANTA — The standard approach of maintaining hematocrit levels less than 45% in patients with polycythemia vera was associated with a lower risk of thrombosis than the less aggressive strategy ...
Treatment guidelines in PV currently recommend maintaining hematocrit below 45%, with a higher threshold for men vs women. 2 For part 2 of this interview, Kuykendall explains the reasoning behind ...
The treatment intervention was halted on June 24, 1996, by which time a total of 1265 patients had been randomly assigned to a study group: 634 to the normal-hematocrit group and 631 to the low ...
Testosterone increased by 145.3 ng/dL from an initial mean of 278.9 ng/dL (P < 0.001). There was an inverse correlation between pretreatment hematocrit and the expected change in hematocrit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results